nanoTherics Ltd was formed in August 2007 to exploit a novel gene transfection technology arising from biomedical research at Keele University and the University of Florida. The patented technology uses nanoparticles and magnetic fields to facilitate the delivery of foreign DNA into living cells.
nanoTools provides monoclonal and polyclonal antibody development services and products. Besides providing individually tailored custom solutions, the company develops, manufactures and markets phosphorylation and modification - state specific monoclonal antibodies and other innovative reagents for Signal Transduction and Alzheimer research, high throughput screening (HTS) and proteomics.
The company's mission is to commercialize innovative materials, products and processes based on nanotechnology, which are result of research and technology
development of laboratories in the Czech Republic and abroad.
Nanotrons Corporation is a wholly owned subsidiary of Agiltron Inc. Nanotrons' vision is to leverage its proprietary advanced nano-engineering technologies to develop solutions to various 21st century challenges confronted by mankind related to energy, water, environment, and terrorism.
Commercializes nanoscale droplet technology being developed at the University of California, Irvine. The droplet technology provides high-precision, digital control of biochemical processes at the nanoscale.
Nanounity supplies surface science analytical solutions through a range of synergistic products through partnerships with leading instrumentation manufacturers. Their core technologies are microscopy, metrology and spectroscopy.
Nanovea manufactures Profilometers, Mechanical Testers & Tribometers to combine the most advanced testing capabilities in the industry: Scratch/Adhesion, Indentation/Hardness, Wear/Friction & 3D Non-Contact Metrology at Nano, Micro & Macro range. Unlike other manufactures Nanovea also provides Laboratory Services, offering clients availability to the latest technology and optimal results through improvements in testing standards.
An early stage therapeutic drug company, NanoVector Inc. is commercializing a patent pending nanoparticle drug delivery system developed at North Carolina State University. The NanoVector nanoparticle is a plant virus. Central to our technology, this virus, which has evolved over millions of years, has several inherent characteristics essential for a successful nanoparticle delivery system and superior to any designed and engineered by humans.
Nanovia has the capacity for industrial production of nanofibrous material. This capacity is used for manufacturing barrier fabrics introduced to the market under its own brand names Nanovia AntiAllergy, Nanovia AntiMicrobe and Nanovia Waterproof, as well as Nanovia filtration materials. Nanovia offers its own production capacity for custom-made nanofibrous materials for different applications and final products.